世界の疼痛寒冷療法市場(~2025年):製品別(OTC医薬品(ジェル、クリーム、パッチ、ラップ、パッド)、処方デバイス(電動、非電動))、用途別(筋骨格、術後、スポーツ医療)、流通チャネル別(病院、小売)

◆英語タイトル:Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription Devices (Motorized, Non-Motorized), Applications (Musculoskeletal, Post Op, Sports Medicine), Distribution Channel(Hospital, Retail) - Global Forecasts to 2025
◆商品コード:MD4660
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月26日
◆ページ数:187
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の疼痛寒冷療法市場規模が2020年16億ドルから2025年20億ドルまで、年平均4.4%成長すると予測しています。本調査レポートでは、疼痛寒冷療法の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(OTC製品、医薬品、医療機器、処方品)分析、用途別(筋骨格系障害、術後療法、心的外傷後療法、スポーツ傷害)分析、流通チャネル別(病院薬局、小売薬局)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・疼痛寒冷療法の世界市場規模:製品別(OTC製品、医薬品、医療機器、処方品)
・疼痛寒冷療法の世界市場規模:用途別(筋骨格系障害、術後療法、心的外傷後療法、スポーツ傷害)
・疼痛寒冷療法の世界市場規模:流通チャネル別(病院薬局、小売薬局)
・疼痛寒冷療法の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period.”
Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management of pain. Moreover, growing awareness about the availability of cost-effective cooling pain relief products and the ease of application of cold pain therapy products are anticipated to accelerate the adoption of these products in the coming years. However, presence of alternate pain relief products / therapies in the market are likely to hamper the growth of this market.

The recent COVID-19 global pandemic has also impacted the cold pain therapy market. Amid covid pandemic, the reduced access to hospital and retail pharmacies, orthopedic clinics and rehabilitation centers effected the sales growth of the cold therapy products. However, post lockdown the improved access to cold therapy devices through online platforms and the growing number of patients opting for self-medication with over-the-counter cold therapy products including cold gel packs, ointments, and cold sprays, for pain management are some of the key factors likely to drive the long-term growth of the cold pain therapy market.

“The OTC products segment to witness the highest growth rate in cold pain therapy market, by product, during the forecast period.”
The OTC products segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of arthritis and other skeletal diorders and growing patient awareness about the availability OTC products easily to be used at home.

“The musculoskeletal disorders segment accounted for the largest share of the cold pain therapy market, by application, in 2020.”
The latetal flow assays segment accounted for the largest share of the cold pain therapy market in 2020. The rise in the global prevalence of musculoskeletal disorders such as osteoarthritis, back and neck pain , growing geriatric patient population and influx of wide range of cold therapy products for musculoskeletal disorders are some of the factors anticipated to boost the segment growth in the coming years.

“The retail pharmacies segment accounted for the largest share of thecold pain therapy , by distribution channel, in 2020”
The presence of different types of cold therapy products in the retail pharamcies has played a critical role in expanding the reach to different customers. Moreover, ongoing collaborations of retail pharmacies with e-commerec marketplayers and the empahzaing on offering consulting servies to the patients are expected to some of the key factors anticipated to fuel the growth of the segment in the coming years.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The cold pain therapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the adoption of cold therapy products, increasing healthcare expenditures, increasing number of retail and hospital pharamcies in India and China, and growing collaborations among players in the region are also expected to drive pount of care diagnostics market growth in Aisa Pacific.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

The major players operating in the cold pain therapy market are Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US).

Research Coverage
This report studies the cold pain therapy market based on the product, application, distribution challenge, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cold pain therapy market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY USED FOR THE STUDY 27
1.5 MAJOR MARKET STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 31
FIGURE 2 BREAKDOWN OF PRIMARIES: COLD PAIN THERAPY MARKET 32
2.2 MARKET ESTIMATION METHODOLOGY 32
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 33
2.2.2 APPLICATION-BASED MARKET ESTIMATION 34
FIGURE 4 MARKET SIZE ESTIMATION: COLD PAIN THERAPY MARKET 34
2.2.3 PRIMARY RESEARCH VALIDATION 35
2.3 DATA TRIANGULATION 36
FIGURE 5 DATA TRIANGULATION METHODOLOGY 36
2.4 RESEARCH ASSUMPTIONS 37
2.5 RESEARCH LIMITATIONS 37
3 EXECUTIVE SUMMARY 38
FIGURE 6 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 38
FIGURE 7 COLD PAIN THERAPY MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 39
FIGURE 8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020 VS. 2025 (USD MILLION) 39
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE COLD PAIN THERAPY MARKET 40

4 PREMIUM INSIGHTS 42
4.1 COLD PAIN THERAPY MARKET OVERVIEW 42
FIGURE 10 RISING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET GROWTH 42
4.2 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020 43
FIGURE 11 OTC PRODUCTS SEGMENT TO DOMINATE THE COLD PAIN THERAPY MARKET IN 2020 43
4.3 ASIA PACIFIC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL AND COUNTRY 44
FIGURE 12 RETAIL PHARMACIES FORMED THE LARGEST DISTRIBUTION CHANNEL SEGMENT IN THE APAC COLD PAIN THERAPY MARKET IN 2020 44
4.4 COLD PAIN THERAPY MARKET, BY REGION 45
FIGURE 13 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2020–2025) 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 14 COLD PAIN THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 46
5.2.1 DRIVERS 47
5.2.1.1 Increasing incidence of sports injuries and rising emphasis on exercise and gym activities 47
5.2.1.2 Growing number of hip and knee surgeries across the globe 48
5.2.1.3 Rising geriatric population and subsequent growth in the prevalence of bone diseases and trauma injuries 48
5.2.1.4 Growing need for safer pain management modalities as opposed to oral drug therapy 49
5.2.1.5 Clinical evidence in favor of menthol-based topical analgesics 49
5.2.2 RESTRAINTS 50
5.2.2.1 High usage of low-priced analgesic pills for immediate pain relief 50
5.2.2.2 Lack of reimbursement 50
5.2.2.3 Lack of substantial clinical evidence in favor of cold pain therapy 50
5.2.2.4 Health hazards and discomfort associated with cold pain therapy products 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Growing adoption of analgesic patches 51
5.2.3.2 Growing use of cold pain therapy among middle-aged women 51
5.2.3.3 Increasing regulatory barriers for oral pain medications 52
5.2.4 CHALLENGES 52
5.2.4.1 Availability of alternative non-drug/device pain management therapies 52
5.3 GLOBAL REGULATORY LANDSCAPE 53

5.4 PRICING TREND ANALYSIS 54
TABLE 1 COLD PAIN THERAPY PRODUCTS PRICING, BY COUNTRY, 2019 (USD) 54
5.5 INDUSTRY TRENDS RELATED TO COVID-19 55
5.6 VALUE CHAIN ANALYSIS 55
FIGURE 15 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING THE REGULATION AND DISTRIBUTION STAGES 55
5.7 ECOSYSTEM COVERAGE: PARENT MARKET (ORTHOPEDIC DEVICES MARKET) 56
5.8 PORTER’S FIVE FORCES ANALYSIS 57
TABLE 2 COLD PAIN THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 57
6 COLD PAIN THERAPY MARKET, BY PRODUCT 58
6.1 INTRODUCTION 59
TABLE 3 COLD PAIN THERAPY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 59
6.2 OTC PRODUCTS 59
TABLE 4 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 60
TABLE 5 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY APPLICATION,
2018–2025 (USD MILLION) 60
TABLE 6 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 60
TABLE 7 COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY REGION,
2018–2025 (USD MILLION) 61
6.3 PHARMACEUTICALS 61
TABLE 8 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE,
2018–2025 (USD MILLION) 61
TABLE 9 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY APPLICATION, 2018–2025 (USD MILLION) 62
TABLE 10 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 62
TABLE 11 COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY REGION, 2018–2025 (USD MILLION) 63
6.3.1 GELS, OINTMENTS, AND CREAMS 63
6.3.1.1 Gels, ointments, and creams offer effective orthopedic pain management therapy over oral drugs 63
TABLE 12 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS,
BY REGION, 2018–2025 (USD MILLION) 64
TABLE 13 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS,
BY APPLICATION, 2018–2025 (USD MILLION) 64
TABLE 14 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS,
BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 64
6.3.2 SPRAYS AND FOAMS 65
6.3.2.1 Procedural benefits offered by sprays and foams to increase their adoption among sportspersons 65
TABLE 15 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY REGION,
2018–2025 (USD MILLION) 65
TABLE 16 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY APPLICATION, 2018–2025 (USD MILLION) 66
TABLE 17 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 66
6.3.3 PATCHES 66
6.3.3.1 Ability to deliver a consistent dosage of drug over topical creams is resulting in the greater consumption of cold pain patches 66
TABLE 18 COLD PAIN THERAPY MARKET FOR PATCHES, BY REGION,
2018–2025 (USD MILLION) 67
TABLE 19 COLD PAIN THERAPY MARKET FOR PATCHES, BY APPLICATION,
2018–2025 (USD MILLION) 67
TABLE 20 COLD PAIN THERAPY MARKET FOR PATCHES, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 68
6.3.4 ROLL-ONS 68
6.3.4.1 Inconsistent drug delivery and the need for repetitive usage on the skin are expected to hamper their adoption 68
TABLE 21 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY REGION,
2018–2025 (USD MILLION) 68
TABLE 22 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY APPLICATION,
2018–2025 (USD MILLION) 69
TABLE 23 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 69
6.4 MEDICAL DEVICES 69
TABLE 24 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE,
2018–2025 (USD MILLION) 70
TABLE 25 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY APPLICATION, 2018–2025 (USD MILLION) 70
TABLE 26 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 70
TABLE 27 COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY REGION, 2018–2025 (USD MILLION) 71
6.4.1 COLD PACKS 71
6.4.1.1 Cold packs are among the widely used cold pain therapy medical devices 71
TABLE 28 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY APPLICATION,
2018–2025 (USD MILLION) 71
TABLE 29 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 72
TABLE 30 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY REGION,
2018–2025 (USD MILLION) 72
6.4.2 COOLING TOWELS, COMPRESSES, WRAPS, AND PADS 72
6.4.2.1 Growing availability of wraps and cooling pads to aid the growth of this market segment 72
TABLE 31 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY REGION, 2018–2025 (USD MILLION) 73
TABLE 32 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY APPLICATION, 2018–2025 (USD MILLION) 73
TABLE 33 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY DISTRIBUTION CHANNEL,
2018–2025 (USD MILLION) 74

6.5 PRESCRIPTION PRODUCTS 74
TABLE 34 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 74
TABLE 35 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY APPLICATION, 2018–2025 (USD MILLION) 75
TABLE 36 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 75
TABLE 37 COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY REGION, 2018–2025 (USD MILLION) 75
6.5.1 MOTORIZED DEVICES 76
6.5.1.1 Preference for motorized devices is increasing among patients 76
TABLE 38 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY APPLICATION, 2018–2025 (USD MILLION) 76
TABLE 39 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 77
TABLE 40 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY REGION,
2018–2025 (USD MILLION) 77
6.5.2 NON-MOTORIZED DEVICES 77
6.5.2.1 Non-motorized devices cost lower as compared to motorized devices 77
TABLE 41 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES,
BY APPLICATION, 2018–2025 (USD MILLION) 78
TABLE 42 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES,
BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 78
TABLE 43 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY REGION, 2018–2025 (USD MILLION) 79
7 COLD PAIN THERAPY MARKET, BY APPLICATION 80
7.1 INTRODUCTION 81
TABLE 44 COLD PAIN THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 81
7.2 MUSCULOSKELETAL DISORDERS 81
7.2.1 INCREASING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 81
TABLE 45 COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS,
BY REGION, 2018–2025 (USD MILLION) 82
7.3 POST-OPERATIVE THERAPY 82
7.3.1 INCREASING NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 82
TABLE 46 COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2018–2025 (USD MILLION) 83
7.4 POST-TRAUMA THERAPY 83
7.4.1 INCREASING INCIDENCE OF TRAUMA INJURIES TO PROPEL THE GROWTH OF THIS MARKET SEGMENT 83
TABLE 47 COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2018–2025 (USD MILLION) 84

7.5 SPORTS INJURIES 84
7.5.1 GROWING NUMBER OF SPORTS INJURIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 84
TABLE 48 COLD PAIN THERAPY MARKET FOR SPORTS MEDICINE, BY REGION,
2018–2025 (USD MILLION) 85
8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL 86
8.1 INTRODUCTION 87
TABLE 49 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2018–2025 (USD MILLION) 87
8.2 HOSPITAL PHARMACIES 87
8.2.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 87
TABLE 50 COLD PAIN THERAPY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2018–2025 (USD MILLION) 88
8.3 RETAIL PHARMACIES 88
8.3.1 RETAIL PHARMACIES FORM THE LARGEST DISTRIBUTION CHANNEL FOR COLD PAIN THERAPY PRODUCTS 88
TABLE 51 COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION,
2018–2025 (USD MILLION) 89
8.4 E-PHARMACIES 89
8.4.1 E-PHARMACIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 89
TABLE 52 COLD PAIN THERAPY MARKET FOR E-PHARMACIES, BY REGION,
2018–2025 (USD MILLION) 90
9 COLD PAIN THERAPY MARKET, BY REGION 91
9.1 INTRODUCTION 92
TABLE 53 COLD PAIN THERAPY MARKET, BY REGION, 2018–2025 (USD MILLION) 92
9.2 NORTH AMERICA 92
FIGURE 16 NORTH AMERICA: COLD PAIN THERAPY MARKET SNAPSHOT 93
TABLE 54 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 93
TABLE 55 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 94
TABLE 56 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 94
TABLE 57 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 94
TABLE 58 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 95
TABLE 59 NORTH AMERICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 95
TABLE 60 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 95
TABLE 61 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 96
9.2.1 US 96
9.2.1.1 Strong presence of market players has driven market growth in the US 96
TABLE 62 US: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 97
TABLE 63 US: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 97
TABLE 64 US: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 97
TABLE 65 US: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 66 US: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 98
9.2.2 CANADA 98
9.2.2.1 Market growth is driven by the rising number of hip and knee replacement surgeries 98
TABLE 67 CANADA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 99
TABLE 68 CANADA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 99
TABLE 69 CANADA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 99
TABLE 70 CANADA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 71 CANADA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 100
9.3 EUROPE 100
TABLE 72 EUROPE: COLD PAIN THERAPY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
TABLE 73 EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 101
TABLE 74 EUROPE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 101
TABLE 75 EUROPE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 102
TABLE 76 EUROPE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 102
TABLE 77 EUROPE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 102
TABLE 78 EUROPE: COLD PAIN THERAPY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 103
TABLE 79 EUROPE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2018–2025 (USD MILLION) 103
9.3.1 GERMANY 103
9.3.1.1 Rising investments to drive market growth in Germany 103
TABLE 80 GERMANY: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 104
TABLE 81 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 104
TABLE 82 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 104
TABLE 83 GERMANY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 84 GERMANY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 105
9.3.2 UK 105
9.3.2.1 Market growth in the UK is mainly driven by the increasing prevalence of musculoskeletal conditions 105
TABLE 85 UK: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 106
TABLE 86 UK: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 87 UK: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 106
TABLE 88 UK: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 107
TABLE 89 UK: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 107
9.3.3 FRANCE 107
9.3.3.1 Increasing target patient population to drive market growth in France 107
TABLE 90 FRANCE: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 108
TABLE 91 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 108
TABLE 92 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 108
TABLE 93 FRANCE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 94 FRANCE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 109
9.3.4 ITALY 109
9.3.4.1 Growing public awareness about the preventive care of musculoskeletal disorders to drive market growth 109
TABLE 95 ITALY: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 110
TABLE 96 ITALY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 97 ITALY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 98 ITALY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 99 ITALY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 111
9.3.5 SPAIN 111
9.3.5.1 Increasing prevalence of target diseases to drive market growth 111
TABLE 100 SPAIN: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 112
TABLE 101 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 102 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 103 SPAIN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 104 SPAIN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 113
9.3.6 REST OF EUROPE 114
TABLE 105 NUMBER OF SURGERIES CONDUCTED IN ROE COUNTRIES 114
TABLE 106 REST OF EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 114
TABLE 107 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 108 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 109 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 110 REST OF EUROPE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 116
9.4 ASIA PACIFIC 116
FIGURE 17 ASIA PACIFIC: COLD PAIN THERAPY MARKET SNAPSHOT 117
TABLE 111 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 117
TABLE 112 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 118
TABLE 113 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 114 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 115 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 116 ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 117 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 119
TABLE 118 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 120
9.4.1 JAPAN 120
9.4.1.1 Japan dominates the Asia Pacific cold pain therapy market 120
TABLE 119 JAPAN: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 120
TABLE 120 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 121 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 122 JAPAN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 123 JAPAN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 122
9.4.2 CHINA 122
9.4.2.1 Expansion in the target patient population to drive market growth 122
TABLE 124 CHINA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 122
TABLE 125 CHINA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 126 CHINA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 127 CHINA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 128 CHINA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 124
9.4.3 INDIA 124
9.4.3.1 Growing number of arthritis cases to drive market growth 124
TABLE 129 INDIA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 124
TABLE 130 INDIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 131 INDIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 132 INDIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 133 INDIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 126
9.4.4 AUSTRALIA 126
9.4.4.1 Rising prevalence of target diseases to drive market growth 126
TABLE 134 AUSTRALIA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 126
TABLE 135 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 136 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 137 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 138 AUSTRALIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 128
9.4.5 SOUTH KOREA 128
9.4.5.1 Supportive government initiatives expected to positively impact market growth 128
TABLE 139 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 128
TABLE 140 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 141 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 142 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 143 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 130
9.4.6 REST OF ASIA PACIFIC 130
TABLE 144 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 130
TABLE 145 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 146 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 147 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 148 REST OF ASIA PACIFIC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 132
9.5 LATIN AMERICA 132
TABLE 149 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 132
TABLE 150 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 133
TABLE 151 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 152 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 153 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 154 LATIN AMERICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 155 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 134
TABLE 156 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 135
9.5.1 BRAZIL 135
9.5.1.1 Growing obese population will drive market growth in Brazil 135
TABLE 157 BRAZIL: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 135
TABLE 158 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 159 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 160 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 161 BRAZIL: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 137
9.5.2 MEXICO 137
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 137
TABLE 162 MEXICO: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 137
TABLE 163 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2018–2025 (USD MILLION) 138
TABLE 164 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 165 MEXICO: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 166 MEXICO: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2018–2025 (USD MILLION) 139
9.5.3 REST OF LATIN AMERICA 139
TABLE 167 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 139
TABLE 168 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 169 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 170 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 171 REST OF LATIN AMERICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 141
9.6 MIDDLE EAST & AFRICA 141
9.6.1 AWARENESS INITIATIVES TO DRIVE THE ADOPTION OF COLD PAIN THERAPY IN THE REGION 141
TABLE 172 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 141
TABLE 173 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 174 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 175 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 176 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 177 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 143
TABLE 178 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018–2025 (USD MILLION) 143
10 COMPETITIVE LANDSCAPE 144
10.1 OVERVIEW 144
FIGURE 18 KEY DEVELOPMENTS IN THE COLD PAIN THERAPY MARKET (2017–2020) 144
10.2 MARKET SHARE ANALYSIS (2019) 145
FIGURE 19 SANOFI HELD THE LEADING POSITION IN THE MARKET IN 2019 145
10.3 COMPETITIVE SCENARIO (2016–2020) 146
FIGURE 20 STRATEGIC OVERVIEW: MAJOR PLAYERS (2016–2020) 146
10.3.1 KEY PRODUCT LAUNCHES AND PRODUCT APPROVALS (2016–2020) 146
10.3.2 KEY EXPANSIONS AND ACQUISITIONS (2016–2020) 147
10.3.3 KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2016–2020) 147
10.4 COMPETITIVE LEADERSHIP MAPPING: MAJOR GLOBAL PLAYERS (AS OF 2019) 148
10.4.1 STARS 148
10.4.2 EMERGING LEADERS 148
10.4.3 PERVASIVE PLAYERS 148
10.4.4 PARTICIPANTS 148
FIGURE 21 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 (MAJOR GLOBAL PLAYERS) 149
10.5 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/ SMES/START-UPS
(AS OF 2019) 150
10.5.1 PROGRESSIVE COMPANIES 150
10.5.2 STARTING BLOCKS 150
10.5.3 RESPONSIVE COMPANIES 150
10.5.4 DYNAMIC COMPANIES 150
FIGURE 22 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING,
2019 (MAJOR SMES/START-UPS) 151
11 COMPANY PROFILES 152
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 BEIERSDORF 152
FIGURE 23 BEIERSDORF: COMPANY SNAPSHOT 152
11.2 BREG, INC. 154
11.3 DJO GLOBAL, INC. 156
FIGURE 24 COLFAX CORPORATION: COMPANY SNAPSHOT 156
11.4 HISAMITSU PHARMACEUTICAL CO., INC. 159
FIGURE 25 HISAMITSU PHARMACEUTICAL CO, INC.: COMPANY SNAPSHOT 159
11.5 MEDLINE INDUSTRIES 162
11.6 ÖSSUR 164
FIGURE 26 ÖSSUR: COMPANY SNAPSHOT 164
11.7 PERFORMANCE HEALTH 166
11.8 JOHNSON & JOHNSON 167
FIGURE 27 JOHNSON & JOHNSON: COMPANY SNAPSHOT 167
11.9 PFIZER 169
FIGURE 28 PFIZER: COMPANY SNAPSHOT 169
11.10 SANOFI 170
FIGURE 29 SANOFI: COMPANY SNAPSHOT 170
11.11 ROHTO PHARMACEUTICAL 172
FIGURE 30 ROHTO PHARMACEUTICAL: COMPANY SNAPSHOT 172
11.12 ROMSONS GROUP OF INDUSTRIES 175
11.13 UNEXO LIFE SCIENCES 176
11.14 3M 177
FIGURE 31 3M: COMPANY SNAPSHOT 177
11.15 BIRD & CRONIN 179
11.16 EMERGING PLAYERS 180
11.16.1 POLAR PRODUCTS 180
11.16.2 RAPID AID 181
11.16.3 MUELLER SPORTS MEDICINE 182
11.16.4 PIC SOLUTION 182
11.16.5 BRUDER HEALTHCARE COMPANY 183
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 184
12.1 DISCUSSION GUIDE 184
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 188
12.3 AVAILABLE CUSTOMIZATIONS 190
12.4 RELATED REPORTS 190
12.5 AUTHOR DETAILS 191



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の疼痛寒冷療法市場(~2025年):製品別(OTC医薬品(ジェル、クリーム、パッチ、ラップ、パッド)、処方デバイス(電動、非電動))、用途別(筋骨格、術後、スポーツ医療)、流通チャネル別(病院、小売)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆